Biovail Settles, Has SAC In Sights

Sep 11 2007 | 7:10am ET

The settlement between Canadian pharmaceutical maker Biovail Corp. and Banc of America Securities could be bad news for hedge fund honcho Steven Cohen and his SAC Capital Management.

E-mail This
Print This
Order Reprints
Twitter
LinkedIn
Facebook.

< Previous Article Next Article >

More News

Q&A: Energy Expert Peter Fusaro Sees Lull In ‘Green’ Investing, Urges Patience

Olympia Launches Half-Index, Half-Fund Of Funds Product
San Diego Pension Will Appeal Amaranth Ruling
British Backed By Cyprus, Malta In Hedge Fund Fight
Cohen Pays $110 Million For Famed Painting
Man Chairman May Join ‘Red Knights’
Family Offices Seek Hedge Fund Talent
Barclays Vets To Launch Banking Hedge Fund In Spain
Divine New Atlanta Hedge Fund Launches
Elliott Out Of MGM Bidding
Missouri Picks Three Hedge Funds, P.E. Shop For Mandates
Saba Adds RenTech Marketer
Hedge Fund Bets On Sex Toy Maker
Church-Based Hedge Fund Fraudsters Plead Guilty
Blackstone Plans $1 Billion Failed-Bank Fund

In Depth

Q&A: Energy Expert Peter Fusaro Sees Lull In ‘Green’ Investing, Urges Patience

Mar 19 2010 | 1:29pm ET

Two year ago cleantech, or green, investing was the strategy du jour....

Lifestyle

Cohen Pays $110 Million For Famed Painting

Mar 19 2010 | 9:50am ET

SAC Capital Advisors founder Steven Cohen has bought on of Jasper John’s famed...

Guest Contributor

Post-Crisis: Hedge Funds, Custodial Risk And Prime Brokers

Mar 16 2010 | 6:45am ET

Just a few years ago prime brokers viewed hedge funds as their main...

Upcoming Events

International Life Settlements Conference -- London
The Wall Street Green Trading Summit -- New York
FT Investing in a Sustainable Future -- New York
Opportunities Arising from OTC Derivatives Reform Legislation -- NYC
What Private Investment Funds Need to Know -- NYC

Biovail Settles, Has SAC In Sights